metoclopramide has been researched along with Postpartum Amenorrhea in 55 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Literature data have demonstrated that the chronic use of metoclopramide (MCP), a dopamine antagonist, causes increased gonadotropin secretion in patients with hypothalamic amenorrhea but without triggering ovulation." | 9.09 | Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin. ( de Sá, MF; Ferriani, RA; Mendes, MC; Moura, MD; Sala, MM, 1999) |
| "The present study was designed to investigate the influence of body weight on the prolactin responsiveness to metoclopramide and thyrotrophin-releasing hormone (TRH) in secondary amenorrhoeic women." | 9.07 | Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women. ( Aono, T; Higuchi, K; Morishita, H; Takemoto, M; Yoshida, J, 1994) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 7.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| "Gonadotropin responses to GnRH and PRL responses to TRH and metoclopramide (MTC) were investigated in nine consecutive women with amenorrhea and insulin-treated diabetes mellitus." | 7.66 | Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus. ( Andersen, AN; Carstensen, L; Djursing, H; Hagen, C; Nyholm, HC, 1983) |
| "The degree of autonomy in prolactin secreting pituitary adenomas and also prolactin secretory reserve in cases with suspected functional galactorrhea syndrome was evaluated with the use of metoclopramide, TRH and L-DOPA." | 7.66 | The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. ( Jeske, W, 1979) |
| "The hypersomnolence was associated with marked elevations in the serum prolactin level." | 5.29 | Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. ( Bamford, CR, 1993) |
| "Literature data have demonstrated that the chronic use of metoclopramide (MCP), a dopamine antagonist, causes increased gonadotropin secretion in patients with hypothalamic amenorrhea but without triggering ovulation." | 5.09 | Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin. ( de Sá, MF; Ferriani, RA; Mendes, MC; Moura, MD; Sala, MM, 1999) |
| "To assess the possible influence of alcoholism on the dopaminergic inhibitory control of prolactin (PRL) secretion, 10 mg of the dopaminergic antagonist metoclopramide (MTC), was injected i." | 5.08 | Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women. ( Coiro, V; Vescovi, PP, 1997) |
| "The present study was designed to investigate the influence of body weight on the prolactin responsiveness to metoclopramide and thyrotrophin-releasing hormone (TRH) in secondary amenorrhoeic women." | 5.07 | Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women. ( Aono, T; Higuchi, K; Morishita, H; Takemoto, M; Yoshida, J, 1994) |
| " The determination of prolactin concentration after the administration of metoclopramide made possible the diagnosis of functional hyperprolactinaemia." | 3.68 | [A case of functional hyperprolactinemia]. ( Kapłon, E; Przybyłowski, J; Siedlecki, J, 1992) |
| "Seven women with stress-induced amenorrhea were challenged with metoclopramide, 10 mg intravenously, before and at the end of a course of clomiphene." | 3.67 | The action of clomiphene in stress-induced amenorrhea. ( Pride, SM; Rowe, TC, 1984) |
| " Furthermore, to evaluate whether high circulating PRL levels influence the activity of the opioid system after the menopause, a group of seven postmenopausal subjects was tested before and 1 week after the administration of metoclopramide (10 mg, three times a day), a dopamine receptor antagonist." | 3.67 | Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. ( Brambilla, F; De Leo, V; Facchinetti, F; Genazzani, AR; Montemagno, U; Nappi, C; Petraglia, F, 1987) |
| " With the TRH-MC test, Prl responses to TRH and MC were significantly lowered in amenorrhoea (N = 8) and hyperprolactinaemia (N = 15) regardless of whether or not treated with bromocriptine, and to MC only in oligomenorrhoea (n = 11)." | 3.67 | Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations. ( Heikkinen, J; Kauppila, A; Viinikka, L, 1986) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 3.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| "The functional activity of endogenous opioids and dopamine (DA) was assessed by analyzing gonadotropin and prolactin responses to DA receptor antagonist (metoclopramide) and the opioid receptor antagonist (naloxone) in selected patients with hypothalamic hypogonadotropic amenorrhea and in normal cycling women." | 3.66 | Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea. ( Casper, RF; Quigley, ME; Sheehan, KL; Yen, SS, 1980) |
| "Gonadotropin responses to GnRH and PRL responses to TRH and metoclopramide (MTC) were investigated in nine consecutive women with amenorrhea and insulin-treated diabetes mellitus." | 3.66 | Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus. ( Andersen, AN; Carstensen, L; Djursing, H; Hagen, C; Nyholm, HC, 1983) |
| "TRH, metoclopramide (MCP), chlorpromazine (CPZ), and insulin (ITT) stimulation tests of PRL secretion were carried out in age-matched controls and before and after successful removal of pituitary prolactinomas in women with the galactorrhea-amenorrhea syndrome." | 3.66 | Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome. ( Blackard, WG; Gardner, DF; Lankford, HV; Tucker, HS, 1980) |
| "The responses of luteinizing hormone, follicle-stimulating hormone, and prolactin to prolonged administration of the dopamine receptor antagonist metoclopramide (5 mg twice daily) were investigated in six normal women and six women with low-weight amenorrhea (LWA)." | 3.66 | Responses of luteinizing hormone, follicle-stimulating hormone, and prolactin to prolonged administration of the dopamine antagonist in normal women and women with low-weight amenorrhea. ( Larsen, S, 1981) |
| "The degree of autonomy in prolactin secreting pituitary adenomas and also prolactin secretory reserve in cases with suspected functional galactorrhea syndrome was evaluated with the use of metoclopramide, TRH and L-DOPA." | 3.66 | The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. ( Jeske, W, 1979) |
| "Administration of a dopamine (DA) antagonist, metoclopramide (MCP) resulted in dose-related acute increments of circulating levels of LH and FSH in patients with hyperprolactinemic anovulation due to pituitary microadenoma but not in normal cycling women during the early follicular phase." | 3.66 | Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. ( Gilliland, GB; Judd, SJ; Quigley, ME; Yen, SS, 1979) |
| "Amenorrhea is one of the cardinal features of anorexia nervosa and is associated with hypothalamic dysfunction." | 2.67 | Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction. ( Golden, NH; Shenker, IR, 1994) |
| "The hypersomnolence was associated with marked elevations in the serum prolactin level." | 1.29 | Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. ( Bamford, CR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (67.27) | 18.7374 |
| 1990's | 17 (30.91) | 18.2507 |
| 2000's | 1 (1.82) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noczyńska, A | 1 |
| Wasikowa, R | 1 |
| Hagen, C | 8 |
| Djursing, H | 9 |
| Petersen, K | 6 |
| Carstensen, L | 3 |
| Quigley, ME | 2 |
| Sheehan, KL | 1 |
| Casper, RF | 1 |
| Yen, SS | 3 |
| Nyholm, HC | 2 |
| Andersen, AN | 7 |
| Rowe, TC | 1 |
| Pride, SM | 1 |
| Lu, YR | 1 |
| Seki, K | 5 |
| Uesato, T | 2 |
| Kato, K | 4 |
| Shima, K | 1 |
| Pedersen, H | 1 |
| Larsen, JF | 1 |
| Tucker, HS | 2 |
| Lankford, HV | 2 |
| Gardner, DF | 1 |
| Blackard, WG | 2 |
| Bohnet, HG | 5 |
| Hanker, JP | 3 |
| Schneider, HP | 4 |
| Grubb, SR | 1 |
| Wigand, JP | 1 |
| Taylon, A | 1 |
| Becker, DP | 1 |
| Larsen, S | 1 |
| Masaoka, K | 1 |
| Naber, NG | 3 |
| Keller, E | 2 |
| Schindler, AE | 1 |
| Andersen, OP | 1 |
| Hansen, P | 1 |
| Madsen, H | 1 |
| Mitsui, C | 1 |
| Nagata, I | 1 |
| Mendes, MC | 2 |
| Ferriani, RA | 2 |
| Costa, LO | 1 |
| Moura, MD | 2 |
| Silva de Sá, MF | 1 |
| Golden, NH | 2 |
| Shenker, IR | 1 |
| Takemoto, M | 1 |
| Morishita, H | 1 |
| Higuchi, K | 1 |
| Yoshida, J | 1 |
| Aono, T | 1 |
| Bamford, CR | 1 |
| Tay, CC | 1 |
| Glasier, AF | 1 |
| McNeilly, AS | 1 |
| Gandar, R | 1 |
| Collin, D | 1 |
| Kato, T | 1 |
| Sekiya, S | 1 |
| Vescovi, PP | 1 |
| Coiro, V | 1 |
| la Marca, A | 1 |
| Morgante, G | 1 |
| De Leo, V | 2 |
| Perkins, RB | 1 |
| Hall, JE | 1 |
| Martin, KA | 1 |
| Sala, MM | 1 |
| de Sá, MF | 1 |
| Jeske, W | 1 |
| Healy, DL | 1 |
| Pepperell, RJ | 1 |
| Stockdale, J | 1 |
| Bremner, WJ | 1 |
| Burger, HG | 1 |
| Judd, SJ | 2 |
| Gilliland, GB | 1 |
| Vázquez-Matute, L | 1 |
| Canales, ES | 1 |
| Alger, M | 1 |
| Zárate, A | 1 |
| del Pozo, E | 1 |
| Lazarus, L | 1 |
| Compton, P | 1 |
| Przybyłowski, J | 1 |
| Siedlecki, J | 1 |
| Kapłon, E | 1 |
| Pepper, GM | 1 |
| Sacker, I | 1 |
| Avruskin, TW | 1 |
| Noll, AM | 1 |
| Pinsky, D | 1 |
| Berga, SL | 1 |
| Loucks, AB | 1 |
| Rossmanith, WG | 1 |
| Kettel, LM | 1 |
| Laughlin, GA | 1 |
| Liu, JH | 1 |
| Ohmichi, M | 1 |
| Koike, K | 1 |
| Miyake, A | 1 |
| Tanizawa, O | 1 |
| Boesgaard, S | 1 |
| Fenger, M | 1 |
| Petraglia, F | 1 |
| Nappi, C | 1 |
| Facchinetti, F | 1 |
| Montemagno, U | 1 |
| Brambilla, F | 1 |
| Genazzani, AR | 1 |
| Langner, TK | 1 |
| Mel'nichenko, GA | 1 |
| Dedov, II | 1 |
| Saakian, OA | 1 |
| Gitel', EP | 1 |
| Kauppila, A | 1 |
| Heikkinen, J | 1 |
| Viinikka, L | 1 |
| Prelević, GM | 1 |
| Würzburger, MI | 1 |
| Perić, LA | 1 |
| Porias Cuéllas, HL | 1 |
| Hernández Bueno, JA | 1 |
| Villanueva, C | 1 |
| Benavides, S | 1 |
| Cortés-Gallegos, V | 1 |
| Harris, RT | 1 |
| Wolf, AS | 1 |
| Christensen, NJ | 1 |
| Tvede, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Baselines in Reproductive Disorders[NCT00456274] | 180 participants (Anticipated) | Interventional | 1999-09-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for metoclopramide and Postpartum Amenorrhea
| Article | Year |
|---|---|
[Functional hypothalamic amenorrheas. I. Physiopathology].
Topics: Amenorrhea; Corticotropin-Releasing Hormone; Female; Gonadotropin-Releasing Hormone; Humans; Hypotha | 1993 |
Eating disorders: diagnosis and management by the internist.
Topics: Adolescent; Adult; Amenorrhea; Anorexia Nervosa; Attitude; Behavior Therapy; Body Weight; Depressive | 1986 |
6 trials available for metoclopramide and Postpartum Amenorrhea
| Article | Year |
|---|---|
Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction.
Topics: Amenorrhea; Anorexia Nervosa; Dopamine; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamus | 1994 |
Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.
Topics: Adult; Amenorrhea; Body Weight; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lu | 1994 |
Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women.
Topics: Adult; Alcoholism; Amenorrhea; Dopamine Antagonists; Female; Humans; Menstrual Cycle; Metoclopramide | 1997 |
Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Amenorrhea; Clonidine; Dopamine Antagonists; Estradiol | 1999 |
Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin.
Topics: Adult; Amenorrhea; Clomiphene; Dopamine Antagonists; Double-Blind Method; Drug Therapy, Combination; | 1999 |
Prolonged dopamine receptor blockade in normoprolactinemic amenorrhea: a double-blind placebo study.
Topics: Adult; Amenorrhea; Clinical Trials as Topic; Double-Blind Method; Female; Follicle Stimulating Hormo | 1986 |
47 other studies available for metoclopramide and Postpartum Amenorrhea
| Article | Year |
|---|---|
Hyperprolactinemia in children during the peripubertal period--personal observations.
Topics: Adolescent; Age Factors; Amenorrhea; Biomarkers; Female; Galactorrhea; Gynecomastia; Humans; Hyperpr | 2004 |
Metoclopramide for normoprolactinaemic amenorrhoea.
Topics: Adult; Amenorrhea; Body Weight; Female; Humans; Metoclopramide; Prolactin | 1983 |
Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Topics: Adult; Amenorrhea; Dopamine; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hypogonadism; | 1980 |
Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
Topics: Adult; Amenorrhea; Diabetes Complications; Diabetes Mellitus; Female; Follicle Stimulating Hormone; | 1983 |
[Dopamine and ovulation. Physiology and physiopathology].
Topics: Amenorrhea; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizin | 1983 |
The action of clomiphene in stress-induced amenorrhea.
Topics: Adult; Amenorrhea; Clomiphene; Dopamine; Estradiol; Female; Follicle Stimulating Hormone; Gonadotrop | 1984 |
[Clinical application of TRH and metoclopramide (MCP) stimulating tests for prolactin].
Topics: Adult; Amenorrhea; Female; Humans; Male; Metoclopramide; Middle Aged; Pituitary Gland, Anterior; Pit | 1983 |
Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
Topics: Adult; Amenorrhea; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypothal | 1984 |
Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
Topics: Adenoma; Adult; Amenorrhea; Female; Humans; Luteinizing Hormone; Metoclopramide; Pituitary Gland, An | 1984 |
Preserved prolactin fluctuations and response to metoclopramide in ovulatory, infertile, hyperprolactinemic women.
Topics: Adult; Amenorrhea; Anovulation; Estradiol; Female; Humans; Infertility, Female; Metoclopramide; Ovul | 1984 |
Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.
Topics: Amenorrhea; Chlorpromazine; Female; Galactorrhea; Humans; Insulin; Lactation Disorders; Metocloprami | 1980 |
[Diagnosis and therapy of amenorrhea (author's transl)].
Topics: Adult; Amenorrhea; Clomiphene; Endometrium; Estrogen Antagonists; Female; Gonadotropin-Releasing Hor | 1980 |
Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal.
Topics: Adenoma; Adult; Amenorrhea; Chlorpromazine; Female; Follow-Up Studies; Galactorrhea; Humans; Lactati | 1981 |
Responses of luteinizing hormone, follicle-stimulating hormone, and prolactin to prolonged administration of the dopamine antagonist in normal women and women with low-weight amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Child; Female; Follicle Stimulating Hormone; Humans; Lut | 1981 |
[The role of the dopaminergic mechanism in the regulation of pituitary hormone secretion in women (author's transl)].
Topics: Amenorrhea; Castration; Dopamine; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormo | 1982 |
Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
Topics: Adult; Amenorrhea; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Met | 1982 |
Modulation of pituitary LH and prolactin pools in amenorrheic women. I. Effects of high dose estrogen or gestagen treatment.
Topics: Amenorrhea; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; | 1980 |
Modulation of pituitary LH and prolactin pools in amenorrheic women. II. Effects of low dose estrogen treatment.
Topics: Amenorrhea; Clomiphene; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormo | 1980 |
Hyperprolactinemic amenorrhea induced by metoclopamide (PrimperanR).
Topics: Adult; Amenorrhea; Female; Humans; Metoclopramide; Prolactin | 1981 |
Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women.
Topics: Adrenocorticotropic Hormone; Adult; Amenorrhea; beta-Endorphin; Dopamine Antagonists; Female; Humans | 1995 |
Cortisol levels alter the response to metoclopramide in patients with hypothalamic amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Anorexia Nervosa; Dopamine; Estradiol; Female; Follicle Stimulating H | 1995 |
Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide.
Topics: Adult; Amenorrhea; Arthritis, Rheumatoid; Disorders of Excessive Somnolence; Estrogen Replacement Th | 1993 |
Effect of antagonists of dopamine and opiates on the basal and GnRH-induced secretion of luteinizing hormone, follicle stimulating hormone and prolactin during lactational amenorrhoea in breastfeeding women.
Topics: Amenorrhea; Breast Feeding; Dopamine; Dopamine Antagonists; Endorphins; Female; Follicle Stimulating | 1993 |
Corticotrophin and vasopressin responses to metoclopramide in patients with hypothalamic amenorrhoea.
Topics: Adrenocorticotropic Hormone; Adult; Amenorrhea; Arginine Vasopressin; Dopamine Antagonists; Female; | 1997 |
Evaluation of hypothalamic-pituitary-adrenal axis in amenorrhoeic women with insulin-dependent diabetes.
Topics: Adult; Amenorrhea; Circadian Rhythm; Corticotropin-Releasing Hormone; Diabetes Mellitus, Type 1; Fem | 1999 |
The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Topics: Acromegaly; Adenoma; Adult; Amenorrhea; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; | 1979 |
Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Topics: Adult; Amenorrhea; Bromocriptine; Clomiphene; Female; Galactorrhea; Humans; Hypothalamo-Hypophyseal | 1977 |
Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Topics: Adenoma; Adult; Amenorrhea; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menst | 1979 |
Clinical use of metoclopramide test in the diagnosis of women with hyperprolactinemia.
Topics: Adult; Amenorrhea; Female; Galactorrhea; Humans; Male; Metoclopramide; Pituitary Neoplasms; Pregnanc | 1979 |
Effects of synthetic gestagens on serum prolactin and growth hormone secretion in amenorrheic patients.
Topics: Amenorrhea; Breast Neoplasms; Female; Growth Hormone; Humans; Medroxyprogesterone; Metoclopramide; N | 1978 |
Hyperprolactinaemia: its physiology and investigation.
Topics: Adenoma, Chromophobe; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Male; Metabolic Disea | 1976 |
[A case of functional hyperprolactinemia].
Topics: Adult; Amenorrhea; Female; Galactorrhea; Humans; Hyperprolactinemia; Metoclopramide; Neurotic Disord | 1992 |
The effects of a dopamine antagonist on luteinizing hormone and prolactin release in women with anorexia nervosa and in normal controls.
Topics: Adolescent; Adult; Amenorrhea; Anorexia Nervosa; Dopamine Agents; Estradiol; Female; Humans; Luteini | 1992 |
Withdrawal effects of metoclopramide.
Topics: Adult; Amenorrhea; Drug Therapy, Combination; Female; Humans; Metoclopramide; Peptic Ulcer; Substanc | 1991 |
Acceleration of luteinizing hormone pulse frequency in functional hypothalamic amenorrhea by dopaminergic blockade.
Topics: Adult; Amenorrhea; Circadian Rhythm; Dopamine Antagonists; Female; Humans; Hypothalamus; Kinetics; L | 1991 |
Hypothalamic amenorrhea: clinical perspectives, pathophysiology, and management.
Topics: Amenorrhea; Anovulation; Dopamine; Endorphins; Estradiol; Female; Follicle Stimulating Hormone; Gona | 1990 |
A simple rapid method for prolactin assay by reversed passive hemagglutination: evaluation of its clinical application.
Topics: Amenorrhea; Antibodies, Monoclonal; Bromocriptine; Female; Hemagglutination Tests; Humans; Metoclopr | 1989 |
Cortisol secretion in patients with normoprolactinemic amenorrhea.
Topics: Adrenocorticotropic Hormone; Adult; Amenorrhea; Diabetes Mellitus, Type 1; Female; Humans; Hydrocort | 1988 |
Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Topics: Adenoma; Adult; Amenorrhea; Antipsychotic Agents; Dopamine Antagonists; Endorphins; Female; Humans; | 1987 |
[Diagnostic value of pharmacological tests and roentgenoradiological methods in the diagnosis of various forms of hyperprolactinemic hypogonadism].
Topics: Adult; Amenorrhea; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Metoclopra | 1986 |
Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Metocloprami | 1986 |
Blunted prolactin response to metoclopramide in insulin-dependent diabetic patients with secondary amenorrhoea.
Topics: Adult; Amenorrhea; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Follicle Stimulating | 1987 |
[The physiopathological aspects of the normoprolactinemic amenorrhea-galactorrhea syndrome].
Topics: Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Metoclopramide; Prolact | 1987 |
Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
Topics: Adult; Amenorrhea; Estradiol; Female; Growth Hormone; Humans; Hyperprolactinemia; Injections, Intrav | 1986 |
Gonadotropin secretion before and during acute and chronic dopamine-receptor blockade in insulin-dependent diabetic patients with amenorrhea.
Topics: Adolescent; Adult; Amenorrhea; Diabetes Mellitus, Type 1; Estradiol; Female; Follicle Stimulating Ho | 1985 |
Treatment of hyperprolactinemic amenorrhea with Metergoline.
Topics: Adenoma; Adult; Amenorrhea; Ergolines; Female; Humans; Hyperprolactinemia; Metergoline; Metocloprami | 1986 |
Abnormal conjugated dopamine levels in patients with normoprolactinaemic amenorrhoea and in insulin-dependent diabetic patients.
Topics: Adult; Amenorrhea; Catecholamines; Diabetes Mellitus, Type 1; Dopamine; Female; Humans; Metocloprami | 1985 |